Randomized, double-blind trial of cefonicid and nafcillin in the treatment of skin and skin structure infections
Open Access
- 1 April 1990
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 34 (4) , 654-656
- https://doi.org/10.1128/aac.34.4.654
Abstract
We compared treatment with one daily intravenous dose of cefonicid and multidose nafcillin in 65 patients with severe infections of the skin or skin structure. Clinical cure or improvement was achieved in 91% of the patients given cefonicid and in 87% of the patients given nafcillin (P = 0.97). The use of cefonicid may allow outpatient therapy of some severe infections.This publication has 5 references indexed in Scilit:
- Overview of bacterial infections of the skin and soft tissue and clinical experience with ticarcillin plus clavulanate potassium in their treatmentThe American Journal of Medicine, 1985
- Once-daily ceftriaxone for skin and soft tissue infectionsAntimicrobial Agents and Chemotherapy, 1985
- Comparison of Cefonicid and Cefazolin for Treatment of Soft-Tissue InfectionsClinical Infectious Diseases, 1984
- Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen.1984
- Cefonicid kinetics in subjects with normal and impaired renal functionClinical Pharmacology & Therapeutics, 1984